SCHEMBL6839795

SCHEMBL6839795

NC(=O)c1cccc(N2CCCCC2CNc2ccc(N3CCCCC3=O)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.47
NPC1 O15118 7/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HPGD P15428 4/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KDM1A O60341 1/20 0.44
MAOB P27338 1/20 0.44
F10 P00742 1/20 0.44
TP53 P04637 2/20 0.44
GLA P06280 1/20 0.44
PKM P14618 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840699 0.83 HPGD (0.45) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6842234 0.82 KDM1A (0.49) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6835604 0.80 KDM1A (0.49) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6835601 0.79 LMNA (0.52) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6807106 0.77 F10 (0.53) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL5163935 0.75 F10 (0.55) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6839698 0.74 KDM1A (0.44) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6835561 0.74 F10 (0.44) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6842250 0.73 KDM1A (0.47) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL6842273 0.73 KDM1A (0.59) RAB9ANPC1SMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1496361-A Phenyl derivatives 3 Ĭ��ר���ɷ����޹�˾ 2004-05-12 CN claimed
US-20040082563-A1 Phenyl derivatives 3 MERCK PATENT GMBH (DE) 2004-04-29 US claimed
EP-1368341-A1 PHENYL DERIVATIVES 3 MERCK PATENT GmbH (DE) 2003-12-10 EP claimed
WO-2002074765-A1 PHENYL DERIVATIVES 3 MERCK PATENT GMBH (DE) 2002-09-26 WO claimed
CN-1496361-A Phenyl derivatives 3 Ĭ��ר���ɷ����޹�˾ 2004-05-12 CN disclosed
US-20040082563-A1 Phenyl derivatives 3 MERCK PATENT GMBH (DE) 2004-04-29 US disclosed
EP-1368341-A1 PHENYL DERIVATIVES 3 MERCK PATENT GmbH (DE) 2003-12-10 EP disclosed
WO-2002074765-A1 PHENYL DERIVATIVES 3 MERCK PATENT GMBH (DE) 2002-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082563-A1 Phenyl derivatives 3 F2, F11, F12 RAB9A 1592/4885NPC1 2264/4885SMN1; SMN2 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.